Seller record · Telehealth service
Ivy Rx
Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named; the pages say medication is prepared in a state-licensed pharmacy compliant with 503B and USP 797 standards and filled at a partner pharmacy. 1 more criterion also fails; see the table below.
At a glance
Ivy RxTelehealth service
- Price
- Compounded GLP-1 injections from $77 a month, microdose from $69
- Sells
- compounded GLP-1 injections (semaglutide and tirzepatide), and 16 more
- FDA letters
- None on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A Miami telehealth service selling compounded GLP-1 injections at one price for every dose, a microdose GLP-1 plan, brand Mounjaro and Ozempic, sermorelin, NAD+, glutathione and B12 injections, and BPC-157 capsules sold as a supplement. The order path opens on a health questionnaire, and it names no filling pharmacy.
Operating entity Ivy Rx, PLLC
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's website |
| S2 | Prescription gating | PASS | Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's GLP-1 MD page on its app site |
| S3 | Pharmacy identification | FAIL | Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's website; Ivy Rx's terms of service page |
| S4 | Compounding disclosure | PASS | Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's safety information page |
| S5 | Analytical documentation | FAIL | Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's microdose GLP-1 injections product page |
| S6 | Business address | PASS | Ivy Rx's contact page; Ivy Rx's privacy policy |
| S7 | Price disclosure | PASS | Ivy Rx's personalized GLP-1 injections product page; Ivy Rx's microdose GLP-1 injections product page; Ivy Rx's Mounjaro product page; Ivy Rx's website; Ivy Rx's sermorelin injection product page; Ivy Rx's peptides page; Ivy Rx's BPC-157 product page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded GLP-1 injections (semaglutide and tirzepatide), microdose GLP-1 injections, Mounjaro, Ozempic, sermorelin injection, NAD+ injection, NAD+ nasal spray, glutathione injection, glutathione nasal spray, MIC + B12 injection, B12 injection, BPC-157 capsules, gut peptide complex, GLP-1 boost, metformin, methylene blue, anti-nausea tablets.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathioneWho sells BPC-157
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.